$4.99
0.06[1.22%]
At close: Jun 12
$4.99
0[0.00%]
After Hours: 4:00PM EDT
Macrogenics
(NASDAQ:MGNX)Macrogenics Stock (NASDAQ:MGNX), Quotes and News Summary
Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.
| Open | $4.970 |
| Close | $4.990 |
| Volume / Avg. | 1.403M / 2.475M |
| Day Range | 4.890 - 5.190 |
| 52 Wk Range | 3.140 - 21.880 |
| Market Cap | $312.541M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 19.43% |
| Days to Cover | 4.77 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Macrogenics (MGNX) stock?
You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.
Who are Macrogenics (MGNX) competitors?
Other companies in Macrogenics’s space includes: Skye Bioscience (NASDAQ:SKYE), Inozyme Pharma (NASDAQ:INZY), Adaptimmune Therapeutics (NASDAQ:ADAP), Agenus (NASDAQ:AGEN) and Monte Rosa Therapeutics (NASDAQ:GLUE).
What is the target price for Macrogenics (MGNX) stock?
There is no analysis for Macrogenics
Current Stock Price for Macrogenics (MGNX)?
The stock price for Macrogenics (NASDAQ: MGNX) is $4.99 last updated June 12, 2024 at 4:00 PM EDT.
Does Macrogenics (MGNX) pay a dividend
There are no upcoming dividends for Macrogenics.
When is Macrogenics (NASDAQ:MGNX) reporting earnings?
Macrogenics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Macrogenics (MGNX) going to split?
There is no upcoming split for Macrogenics.
What sector and industry does Macrogenics (MGNX) operate in?
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.